We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maximilian Konig

Maximilian F. Konig MD

Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD

Dr. Konig is a rheumatologist at the Johns Hopkins University School of Medicine in Baltimore. He received his medical degree from Charité - Universitätsmedizin Berlin and completed his residency training at Massachusetts General Hospital and fellowship in rheumatology at the Johns Hopkins Hospital. He has a long-standing interest in mechanisms of disease initiation and propagation in autoimmune rheumatic disease, particularly the role of periodontitis in rheumatoid arthritis (RA). 

In his work with Dr. Felipe Andrade, they identified Aggregatibacter actinomycetemcomitans leukotoxin A as a driver of neutrophil hypercitrullination in periodontitis, linking Aa to the immunopathogenesis of RA (Konig MF et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med. 2016;8(369):369ra176. doi:10.1126/scitranslmed.aaj1921).